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ABSTRACT 
HR-pQCT is a non-invasive imaging modality for assessing volumetric BMD (vBMD) and 
microarchitecture of cancellous and cortical bone. The objective was to (i) assess fracture-
associated differences in HR-pQCT bone parameters and (ii) to determine if HR-pQCT is 
precise enough to reliably detect these differences in individuals. We systematically identified 
40 studies that used HR-pQCT (39/40 used XtremeCT I scanner) to assess 1291 to 3253 
individuals with- and 3389 to 10,687 individuals without- incident or prevalent fractures, 
ranging in age from 10.9 to 84.7 years with no comorbid conditions. Parameters describing 
radial and tibial bone density, microarchitecture, and strength were extracted and percentage 
differences between fracture and control subjects were estimated using a random effects meta-
analysis model. An additional meta-analysis of short-term in vivo reproducibility of bone 
parameters assessed by XtremeCT I was conducted to determine whether fracture-associated 
differences exceeded the least significant change (LSC) required to discern measured 
differences from precision error. Radial and tibial HR-pQCT parameters, including failure 
load, were significantly altered in fracture subjects, with differences ranging from −2.6% (95% 
CI: −3.4 to −1.9) in radial cortical vBMD to −12.6% (95% CI: −15.0 to −10.3) in radial 
trabecular vBMD. Fracture-associated differences reported by prospective studies were 
consistent with those from retrospective studies, indicating that HR-pQCT parameters can 
predict incident fracture. Assessment of study quality, heterogeneity and publication biases 
verified the validity of these findings. Finally, we demonstrated that fracture-associated deficits 
in total and trabecular vBMD, and certain tibial cortical parameters, can be reliably discerned 
from HR-pQCT-related precision error and thus can be used to detect fracture-associated 
differences in individual patients. Although differences in other HR-pQCT measures, including 
failure load, were significantly associated with fracture, improved reproducibility is needed to 
31 October 2019 Confidential [MEBP013] 
MEBP013A_ms draft_FINAL_revised_tracked_100719.docx 3 
ensure reliability in individual patient cross-sectional screening and longitudinal monitoring. 
In conclusion, our study supports the use of HR-pQCT in clinical fracture prediction.  
Keywords 
Bone QCT, fracture risk assessment, analysis/quantitation of bone, clinical trials, statistical 
methods 
Introduction 
The use of bone imaging outcomes to predict fracture risk is important in clinical assessment 
of bone health. Currently, the gold standard for clinical imaging of bone mass is DXA. DXA-
derived areal BMD(aBMD) is a significant predictor of fracture risk; however, its predictive 
value is limited because: (i) the aBMD in most older individuals that experience a fracture is 
outside the osteoporotic range (T-Score < −2.5),(1,2) (ii) it does not differentiate between the 
cortical and cancellous bone compartment, and (iii) additional information on bone 
microarchitecture – which is an indicator of bone quality and predictor of fracture(3-6) – cannot 
be determined.  
HR-pQCT has emerged as a non-invasive imaging modality with an isotropic voxel 
size of 82 µm (XtremeCT I; XCT 1, Scanco Medical, Switzerland) or 61 µm (XtremeCT II; 
XCT II, Scanco Medical, Switzerland), which allows for assessment of volumetric bone density 
and microarchitecture of cortical and cancellous bone compartments. While early studies on 
the association between HR-pQCT measures and fracture have been promising, HR-pQCT 
scanners are predominantly used in a research setting.(7) Until recently,(3-6) HR-pQCT studies 
have been retrospective by design,(8) raising uncertainty about whether the fracture-associated 
differences observed by HR-pQCT are a cause or consequence of the fracture event. Moreover, 
there have been concerns about whether HR-pQCT scans, which are restricted to metaphyseal 
(XCT I) radial and tibial sites, are informative about clinically relevant sites such as spine or 
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hip. Next generation scanners (XCT II) allow imaging of diaphyseal sites, but little data are 
currently available.  
To detect differences in bone between baseline and follow-up measures in an individual 
patient, imaging techniques must be highly reproducible (i.e. precise). A system’s precision 
can be quantified using repeat measures of imaging phantoms, such as the European Forearm 
Phantom (EFP).(9,10) However, when scanning patients, precision error tends to be much higher 
than that assessed by phantoms due to motion artefacts, reference line positioning and operator 
skill. Thus, the reproducibility of HR-pQCT measures is best assessed using repeat measures 
from individual patients. Precision errors are parameter- and scanner-dependent and, once 
characterized, the least significant change (LSC) can be estimated which then informs the user 
of the smallest difference that can confidently be discerned from precision error.(11) For HR-
pQCT to be reliably used in a clinical setting for longitudinal monitoring and cross-sectional 
screening,(12) fracture risk-associated differences in bone must exceed the LSC.  
The objectives of this study were to: (i) conduct a systematic review and meta-analysis 
of studies that investigated the association between fracture and HR-pQCT measures in 
otherwise healthy individuals with and without age-related osteoporosis, and (ii) to determine 
whether HR-pQCT is sufficiently precise to detect fracture-associated differences in individual 
patients. In short, if deficits in HR-pQCT measures are associated with fracture, can these 
deficits be detected at the individual patient level – rather than the cohort level – in the presence 
of measurement error?   
Materials and Methods 
The present study was conducted in a PRISMA-compliant manner(13) – see Table S1 for the 
PRISMA checklist. 
Software 
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Endnote X7 (Thomson Reuters) was used to manage references, the MetaLab meta-analysis 
tool box(14) in MATLAB (Mathworks) and JASP 0.9.01 (JASP Team) were used to conduct 
the meta-analysis, Excel 2016 (Microsoft) was used for data storage and CorelDRAW X8 
(Corel) was used for figure preparation.  
Search strategy and inclusion criteria 
The search strategy was constructed using key terms for ‘HR-pQCT’ and ‘fracture risk’ (Table 
S2).  Medline, Embase, PROSPERO, and Cochrane DSR were searched on February 14, 2018 
and articles were exported to Endnote. Titles and abstracts were screened independently by two 
authors (MMB and KW). Studies were included if HR-pQCT was used to compare bone 
parameters between individuals of all ages with or without fracture. Only individuals that were 
reported as apparently healthy, or with possible age-related osteoporosis, were considered.  
Studies were excluded if outcome reporting was deficient (e.g. unclear or absent measures of 
effect, error or sample size). Only studies published in English were included. Reviews, books, 
letters, editorials, and conference proceedings were excluded. No restrictions were imposed on 
study design, type of fracture assessed, or treatments taken by study participants (e.g. 
bisphosphonates). Eligibility was confirmed by full-text screening of articles. Screening 
conflicts were resolved by consensus as required. The bibliographies of studies identified in 
the primary search were screened for additional studies using the same selection criteria as 
above. 
Quality assessment 
Study quality was assessed using a 9-item quality check-list:(14) HR-pQCT short-term 
reproducibility assessed, fracture history verified by primary report (e.g. radiograph, medical 
report), recruitment from same source (fracture and non-fracture individuals recruited from 
same population), age-matched, random sampling, random matching, informed consent, ethics 
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committee approval, and conflict of interest statements. Data were stratified by aggregate 
quality score to assess the influence of study quality on outcomes. 
Data extraction 
Data were extracted by a single reviewer (MMB) and verified by another (NM). For each study, 
we extracted sample sizes (�∀ : number of fracture subjects, �# : number of non-fracture 
subjects), raw outcomes (�∀: fracture subject outcome, �#: non-fracture subject outcome) and 
error measures [ ��(�) : standard errors, ��(�) : standard deviations] for 11 HR-pQCT  
parameters (Table 1) from individuals with and without fracture. Trabecular bone volume 
fraction (Tb. BV/TV, %) was also extracted from studies and converted to trabecular vBMD 
(Tb. vBMD) [ Tb. vBMD = (1200	mg	hydroxyapatite	(HA)/cmΓ ∙ Tb. BV/TV)/100 ], 
assuming fully mineralized bone has a mineral density of 1200 mg HA/cm3. The MetaLab data 
extraction module was used for graphical data extraction.(14) Study characteristics including 
age, sex, fracture site and trauma degree were recorded for all studies. 
Study-level outcomes 
All measures were extracted as raw values and calculated as percentage differences (���): 
���(%) = �∀ − �#�# × 100%  (1) 
and standard errors ��(���) (15): 
��(���) = ΟΠ��(�#)�# Θ
Ρ + Π��Τ�∀Υ�∀ Θ
Ρ × 100%  (2) 
Assessment of short-term in vivo reproducibility 
A selection of methodological studies from the authors’ library were used to conduct a rapid 
review and meta-analysis of short-term in vivo reproducibility of HR-pQCT measures acquired 
from individual patients by XCT I scanners. These included studies in which within-patient 
reproducibility was assessed between scans following limb repositioning, since error can arise 
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from repositioning of reference lines, motion artefacts and non-overlapping volumes of interest 
(VOI). For each study, the root-mean-squared per cent coefficient of variance (CV%RMS), 
number of subjects (i.e. precision error), number of repeat scans, and scanned regions were 
extracted. Region-specific (radius, tibia) reproducibility was calculated as a weighted mean. 
Weights were degrees of freedom ��	 = 	�(� − 1), where m = number of subjects and n = 
number of repeat scans.(11) Parameter- and region-specific CV%RMS estimates were used to 
compute the LSC required to reliably detect a difference between HR-pQCT measures acquired 
from two separate scans in an individual patient, at a 95% confidence level:(11) 
��� = 1.96 ∙ ∴��%⊥_Ρ + ��%⊥_Ρ = 2.77 ∙ ��%⊥_  (3) 
Throughout this manuscript, ‘reliability of HR-pQCT measures’ refers to how fracture-
associated differences relate to the LSC, where the LSC is interpreted as a metric that assesses 
whether there is sufficient signal over noise to deem a measurement reliable.(12) HR-pQCT 
measures for which fracture-associated differences exceeded the LSC were deemed reliable 
predictors of fracture at the individual patient level.  
Results 
Overview of studies 
Database searches identified 516 unique citations; of these, 36 were eligible for inclusion (Fig. 
1). An additional 13 studies were included from a bibliographic review of the 36 included 
studies, and two more were added from the authors’ library. From the 51 identified studies, 11 
studies focused on populations with comorbid illness/conditions (kidney disease(16-20) [n = 5], 
systemic lupus erythematosus(21,22) [n = 2], idiopathic osteoporosis(23) [n = 1], Sjögren's 
syndrome(24) [n = 1], ankylosing spondylitis(25) [n = 1] and oligo/amenorrhea(26) [n = 1]) and 
were excluded. A study in individuals with diabetes was also identified; however, it was 
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included because non-diabetic cohort data were also reported.(27) In total, 40 studies were 
included in our meta-analysis (Fig. 1). 
Characteristics of studies included in the analysis are presented in Table S3. Most 
studies were conducted in Europe (20/40 [50%]) or North America (17/40 [42.5%]), and the 
remaining studies (3/40 [7.5%]) were conducted in Australia, China or Israel/USA. The number 
of individuals included in our meta-analysis varied for different HR-pQCT parameters, ranging 
from 1291 to 3253 fracture subjects and 3389 to 10 687 non-fracture subjects.  All studies used 
the 1st-generation XCT I scanner (isotropic voxel size of 82 µm) to assess the association 
between tibial and/or radial measures and fracture, with the exception of Fink and colleagues 
(2018) who used the 2nd-generation XCT II scanner (isotropic voxel size of 61 µm).(28) Almost 
all studies reported using standard 9.5 mm (42/42 data sets [100%]) or 22.5 mm (38/39 data 
sets [97.4%]) proximal offsets from the radial and tibial reference lines, respectively, in adults. 
In contrast, pediatric studies tended to use smaller absolute (1.0 mm(29), 2.0 mm(30) or 9.5 
mm(31)) or relative (4% total length(32)) proximal radial offsets. Four studies reported using the 
Strax method for image segmentation and analysis;(6,32-34)  however, one of these also reported 
data acquired by the Scanco method so Strax data were omitted in this case.(6) Although there 
are known inconsistencies between values estimated by the Strax and Scanco algorithms, most 
parameter estimates are linearly related thereby ensuring that proportional changes in either set 
of values are consistent and amenable to being pooled in the current study as percentage 
differences.(35) The most frequently reported fracture sites were ‘any’ (N = 20 studies), forearm 
(N = 12) and vertebral/spine (N = 5).  
Cross-sectional (retrospective) studies were defined as those in which HR-pQCT scans 
were performed following the fracture event. Most studies (36/40 [90%]) were cross-sectional, 
of which half (18/36 [50%]) were case-control studies. Cross-sectional studies tended to focus 
on older female subjects (women [N data sets = 28; median age: 64.9 years, interquartile range 
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(IQR): 47.6–70.1], men [N = 9; median age: 57.0, IQR: 30.0–71.0], girls [N = 3; median age: 
11.8 years, IQR: 11.1–11.8], boys [N = 3; median age: 12.6 years, IQR: 12.0–15.2]). The time 
between fracture and HR-pQCT assessment varied substantially across the cross-sectional 
studies – some reported that fracture occurred at any time before the scan (10/40 studies [25%]) 
or after menopause (5/40 [12.5%]), while others reported time frames ranging from <4 weeks 
to 35.8 years between fracture and scan. Four studies were prospective (4/40 [10%]), in which 
HR-pQCT scans were acquired at baseline and then patients were followed (for 5.0 to 9.4 years) 
for fracture events. Three prospective studies investigated females (median age: 67.1 years, 
IQR: 65.0–68.4) while Szulc and colleagues (2018)(5) was the only prospective study on males 
(mean age: 72.1 years). All four studies included low-trauma fractures (i.e. fragility fractures, 
defined as a fall from a standing position or less) and excluded moderate- to high-trauma 
fractures.  
Radial and tibial HR-pQCT bone parameters discriminate fracture status  
Fracture-associated differences across all studies were assessed in radial and tibial Tb. vBMD 
(Fig. 2) and finite element analysis (FEA)-derived failure load (Fig. 3) as well as additional 
density (Fig. S1-2), microarchitectural (Fig. S3-8), and FEA parameters (Fig. S9).  
HR-pQCT-derived radial and tibial parameters were significantly different between 
fracture and control subjects. Fracture-associated differences increased with age (note that 
forest plots are ordered by age) and were consistently larger in the radius than in the tibia, 
especially for trabecular measures Tb. vBMD (p = 0.02), trabecular thickness (Tb. Th.) (p = 
0.15) and trabecular number (Tb. N.) (p = 0.04). Differences varied considerably across bone 
parameters, ranging from 0.9% (95% CI: −2.6 to 4.5) in radial cortical porosity (Ct. Po.) (Fig. 
S5) to −12.6% (95% CI: −15.0 to −10.3) in radial Tb. vBMD (Fig. 2). Thus, bone quality 
assessment by HR-pQCT can discriminate fracture status in individuals.  
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Quality analysis 
We assessed how study quality influences outcomes. The median study-level quality score was 
7 out of 9. In general, fracture-associated differences were overestimated in lower quality 
studies (Fig. 4, Fig. S10). Study quality explained from 11.2% (cortical volumetric BMD [Ct. 
vBMD]) to 30.3% (trabecular thickness [Tb. Th.]) of the observed heterogeneity between 
studies (Fig. 4, Fig. S10). Nonetheless, higher variances reported in lower quality studies 
ensured the overall outcome was not distorted. 
Risk of bias  
Since sampling error is assumed to be random, all study-level outcomes should be 
symmetrically distributed around the most precise estimates. However, parameter-specific 
funnel plots revealed asymmetries for several HR-pQCT measures (Fig. 5, Fig. S11), which is 
suggestive of biased reporting practices which arise when small studies refrain from publishing 
negative results.(36) We used trim-and-fill analysis to examine the effect of publication bias and 
to compute ‘unbiased’ estimates. Bias had a negligible influence on all parameter estimates, 
except Ct. vBMD (Fig. 5C). We concluded that there was minimal risk that the fracture-
associated differences computed in this meta-analysis are an artefact of bias. 
Heterogeneity analysis 
Overall heterogeneity in study-level fracture-associated differences was moderate to high, 
accounting for 39.1% (radial Ct. Po.; Fig. S5) to 81.1% (tibial Ct. vBMD.; Fig. S2) of the 
observed variance in the data.  Single-study exclusion analysis did not identify any influential 
outliers (Fig. 6A, B; Fig. S12A). Using a cumulative-study exclusion approach, the 
homogeneity threshold TH was found to be below 30% for all parameters except Tb. N. and 
trabecular separation (Tb. Sp.), for which TH was 33% and 43%, respectively (Fig. 6C, D; Fig. 
S12B). Importantly, estimates from homogeneous subsets of the data were consistent with 
overall estimates, except Tb. Sp.  
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For cortical thickness (Ct. Th.) and Ct. Po. measures, we assessed if differences in 
parameter estimation methods contributed to heterogeneity. For Ct. Th., the indirect estimation 
method(37) was used in ~50% of studies and yielded significantly lower estimates compared 
with the direct method,(38) used in ~35% of studies (Fig. S4B, C) – even after adjusting for age 
and sex differences (Table S4). For Ct. Po., the majority of studies (90.1%) used a void voxel-
based method,(38) which provided similar estimates of fracture-associated differences compared 
to the density-based method(39) (Fig. S5B, C).  
Taken together, we determined that meta-analytic outcomes were largely unaffected by 
the moderate to high heterogeneity observed between data sets.  
Differences in HR-pQCT bone parameters can predict incident fracture  
Retrospective studies do not inform us whether poor bone quality observed in fracture subjects 
is a cause or consequence of the fracture event. To address this, we separately examined 
fracture-associated differences reported by prospective and retrospective studies (Fig. 7; Table 
S5). All parameters, except Ct. Po., were significantly associated with fractures in retrospective 
and prospective studies. Prospective studies were limited to a relatively homogeneous group 
of older females and males (�Ρ = 0%) with similar fracture types and trauma (Table S3), 
therefore these findings may not be generalized to younger populations. Nevertheless, the 
consistency between prospective and retrospective outcomes is a strong indicator that HR-
pQCT parameters are predictive of incident fracture, even in populations for whom prospective 
data are lacking (e.g. pediatric and young adult populations).  
Reproducibility of HR-pQCT measures and implications for fracture prediction 
For HR-pQCT parameters to be useful in fracture prediction, they must not only be 
significantly associated with fracture, but must also be highly reproducible. We investigated 
the short-term reproducibility of HR-pQCT measures. Short-term reproducibility was assessed 
in 58% of studies (Fig. S13A); however, the quality of reporting was poor because most studies 
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tended to report precision ranges for multiple parameters rather than parameter-specific 
precision estimates. Nonetheless, short-term reproducibility for density-based measures 
( ��%⊥_ = 1.2% ) was significantly better (p < 0.001) than for structural measures 
(��%⊥_ = 3.9%) (Fig. S13B).  
To assess parameter-specific reproducibility, we conducted a rapid review and meta-
analysis of in vivo short-term reproducibility of HR-pQCT measures acquired from individual 
patients, with complete limb repositioning between scans(38,40-50) (Fig. 8A-D; Table S6). 
Consistent with ranges reported in HR-pQCT fracture studies (Fig. S13B), density-related 
measurements (��%⊥_ = 0.8 − 2.0% ; Fig. 8A) were the most precise while Ct. Po. 
(��%⊥_ = 6.2 − 12.5%; Fig. 8B) and trabecular microarchitecture measures (��%⊥_ =
4.1 − 4.9%; Fig. 8C) were the least. By comparison, FEA parameters were moderately precise 
(��%⊥_ = 2.0 − 3.5%; Fig. 8D). Of interest, reproducibility was consistently higher for 
tibial compared with radial parameters, especially for Ct. vBMD (p = 0.04), Ct. Th. (p = 0.08) 
and Ct. Po. (p < 0.001) (Fig. 8A-D; Table S6).  
The least significant change (Eqn. 3) required to reliably detect a difference between 
HR-pQCT measures acquired from separate scans was overlaid with fracture-associated 
differences in radial (Fig. 8E) and tibial (Fig. 8F) HR-pQCT measures. Fracture-associated 
differences in radial and tibial vBMD (Tt. vBMD) and Tb. vBMD were significantly larger 
than the LSC (Fig. 8E, F). Additionally, differences in Ct. vBMD and Ct. Th. exceeded the 
LSC in the tibia (Fig. 8F), but not the radius (Fig. 8E). There were several HR-pQCT measures 
that were in similar ranges as the LSC, specifically radial Ct. Th., stiffness and failure load 
(Fig. 8E), as well as tibial cortical area (Ct. Ar.), Tb. Sp., stiffness and failure load (Fig. 8F). 
These borderline cases in which fracture-associated differences nearly exceed the LSC 
demonstrate a need for improved reproducibility, which may then qualify this subset of HR-
pQCT parameters for fracture prediction.  
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Due to the poor reproducibility and relatively smaller fracture-associated differences, 
Ct. Po., Tb. Th., and Tb. N. are unlikely to serve as reliable predictors of fracture.  
We concluded that radial and tibial Tt. vBMD and Tb. vBMD, as well as tibial Ct. 
vBMD and Ct. Th. can reliably detect fracture-associated differences.  
Discussion 
Overview 
The objective of this study was to demonstrate whether HR-pQCT-derived bone parameters 
can reliably predict fracture. We report that radial and tibial HR-pQCT parameters including 
failure load, were significantly altered in fracture subjects. Differences in HR-pQCT measures 
reported by prospective studies were consistent with those from retrospective studies, 
indicating that HR-pQCT parameters are predictive of incident fracture. Assessment of study 
quality, heterogeneity and publication biases verified the validity of these findings. To further 
support the utility of HR-pQCT, we evaluated whether expected fracture-associated differences 
can be discerned from measurement error at the individual level. Based on our assessment of 
published in vivo short-term reproducibility data, we demonstrate that fracture-associated 
differences in radial or tibial Tt. vBMD and Tb. vBMD, as well as tibial Ct. vBMD and Ct. Th. 
can be reliably detected in individual patients using the XCT I scanner. We conclude that there 
is strong evidence supporting the use of HR-pQCT for fracture prediction in a clinical setting. 
Mechanistic insights 
The current study offers several mechanistic and biological insights. Findings reported by 
retrospective and prospective studies were consistent, indicating that deficits in peripheral bone 
are evident prior to fracture and are not due to deterioration following the fracture event. 
Consistent with a prior meta-analysis of retrospective fracture association studies,(8) we found 
that HR-pQCT can predict fracture at sites other than the periphery, supporting the hypothesis 
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that peripheral bone quality is reflective of clinically relevant sites such as hip and spine.(3,51) 
We also found that fracture-associated trabecular (but not cortical) deficits were consistently 
more pronounced in the radius compared with the weight-bearing tibia. However, this does not 
necessarily mean that the radius has better predictive value than the tibia. A cadaver study by 
Kroker (2017) showed that tibial parameters were better correlated with femoral and lumbar 
failure loads compared with radial parameters.(51) Wang (2016) showed that the association 
between vertebral fractures and FEA-derived failure load was slightly better in the tibia (odds 
ratio [OR] = 1.41, 95% CI: 1.04 to 1.78) than in the radius (OR = 1.15, 95% CI: 0.98 to 1.32). 
Similarly, Zhu (2016) reported that tibial failure load (OR = 3.85, 95% CI: 1.46 to 10.0) was 
more strongly associated with hip fracture than radial failure load (OR = 2.54, 95% CI: 1.09 to 
5.92).(52) These data suggest that FEA parameters for the load-bearing tibia may be more 
representative of clinically relevant fracture sites, which are often load-bearing (e.g. femur, 
vertebra) unlike the radius.  
HR-pQCT reproducibility 
The short- and long-term intra- and inter-scanner reproducibility of HR-pQCT measurements 
is necessary to detect and monitor changes in bone density and microstructure over time in 
individual patients, compare patient data with normative reference data, and pool data from 
different scanners in multicenter trials. Intervention effects may be detected by HR-pQCT even 
if reproducibility is poor with a sufficiently large sample size, because measurement error is 
random. However, poor reproducibility has significant implications on early proof of principle 
and hypothesis-generating studies with small sample sizes and short monitoring time intervals, 
as well as in the clinic where sample size cannot be exploited to offset measurement errors.  
We conducted a rapid meta-analysis of short-term in vivo reproducibility of HR-pQCT 
measures assessed by the XCT I scanner.(38,40-50) Density-related measures had the best 
reproducibility of 0.8–2.0%, which was comparable to DXA-derived aBMD reproducibility 
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(0.8–2.3%).(53) Although there were significant fracture-associated deficits in 
microarchitectural and FEA parameters, the short-term reproducibility reported for the XCT I 
scanner (82 µm voxel size) limits the use of several parameters in clinical screening or 
monitoring applications. By comparison, the higher-resolution XCT II scanner (61 µm voxel 
size) offers substantial improvements in reproducibility for all trabecular parameters (XCT II: 
0.8–2.4%, XCT I: 4.1–4.9%) as well as Ct. Th (XCT II: 1.1–1.2%, XCT I: 1.6–3.6%), but not 
density-based measures (XCT II: 0.6–1.5%, XCT I: 0.8–2.0%) or Ct. Po. (XCT II: 11.0–13.3%, 
XTI: 6.2–12.5%).(49) The XCT II scanner has a nominal voxel size that enables direct 
measurement and improved reproducibility of trabecular parameters,(54) unlike indirect 
methods used by the XCT I which have limited accuracy and precision.(37,41,55) The lack of 
improvement in Ct. Po. precision was unexpected considering the improved precision in other 
parameters. An explanation offered by Chiba and colleagues (2018) was that Ct. Po. estimates 
are small values, and so even the slightest deviation in measurement can manifest as a 
disproportionately pronounced error.(49) Ellouz and colleagues (2014) also suggested that the 
default use of 2D area-matching, rather than 3D image registration, can result in angular 
deviations and, consequently, analysis of slightly different regions, thereby impacting Ct. Po. 
measurement precision.(43) Although additional studies are needed to verify the precision of 
XCT II-derived parameters, the improved reproducibility offered by the 2nd-generation 
scanner is promising. 
Beyond scanner resolution, the reproducibility of HR-pQCT parameters is influenced 
by several factors including image grade (motion artefacts, noise, density),(42) operator skill,(48) 
registration protocol (3D image registration improved precision by 8–23% compared with 2D 
area-matching),(41,43) reference line (positioning of VOIs),(42,48) and scanned region (radius vs 
tibia).(42,45) Regrettably, there remains a lack of consensus and standardization of methods for 
HR-pQCT imaging and analysis, as well as for estimation methods, such as for Ct. Po., Ct. Th., 
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and FEA measures. Only recently has the community coalesced towards scanning a relative 
position at 4.0% (radius) and 7.3% (tibia) of total bone length in adults to avoid limb length 
biases that arise when scanning at a fixed position.(56) Although efforts have been made in terms 
of providing training tools(48) and establishing normative databases,(57) there is an urgent need 
for the HR-pQCT community to consolidate current practices and establish standardized and 
highly reproducible imaging and analysis protocols, and reporting guidelines akin to those 
widely adopted for rodent µCT studies.(58)  
Fracture prediction  
Having established that deficits in HR-pQCT measures are significantly associated with 
fracture, we assessed which parameters had fracture-associated deficits that could be discerned 
from measurement error at the individual level, as opposed to the cohort level where 
measurement errors are a negligible factor. Parameters for which fracture-associated deficits 
exceeded the LSC were deemed reliable predictors of fracture at the individual level.  
Tt. vBMD and Tb. vBMD (and related Tb. BV/TV) were found to be reliable predictors 
of fracture, owing to the high reproducibility of density-based measures and the strong 
association between Tt. vBMD or Tb. vBMD and fracture, which was consistent with the meta-
analysis by Wong (2016).(8) The same meta-analysis also reported that deficits in radial and 
tibial Ct. vBMD and Ct. Th. were strongly associated with all fractures; however, after 
accounting for the reproducibility attained by the XtremeCT I, only tibial Ct. vBMD and Ct. 
Th. could reliably discern fracture-associated deficits from precision error. Importantly, the 
Bone Microarchitecture International Consortium (BoMIC), which combined individual-level 
prospective data from eight cohorts (7254 individuals, mean age: 69 ± 9 years), had reported 
that these parameters – which we showed to be reliable – improve fracture prediction beyond 
femoral neck aBMD or fracture risk assessment tool (FRAX) scores alone.(59) 
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Validation studies have demonstrated that FEA parameters are better predictors of bone 
strength than bone density.(60-62) This was confirmed by the BoMIC study which reported 
superior fracture risk prediction by failure load (hazard ratio [HR] = 1.82–1.98) compared with 
all other HR-pQCT parameters (HR = 1.09–1.44), even after adjusting for DXA femoral neck 
aBMD.(59) However, our work suggests that the superior performance of failure load in fracture 
risk prediction is currently limited by measurement precision. Thus, while there is strong 
evidence demonstrating that failure load is the best predictor of incident fracture at the cohort 
level, HR-pQCT cannot reliably discern fracture-associated differences in failure load from 
precision error at the individual level. We estimate that failure load LSC must be improved to 
below 5% for failure load to be used as a reliable predictor in a clinical setting.  
HR-pQCT and bone diseases 
This meta-analysis was restricted to individuals with no comorbidities or underlying 
conditions, aside from uncomplicated age-related and/or post-menopausal osteoporosis. 
However, many pathologies are associated with a heightened risk of fracture, and HR-pQCT 
may be useful in guiding decisions to treat patients as well as to monitor the efficacy of 
treatment over time. For example, several groups have compared adults with osteogenesis 
imperfecta (OI) to apparently healthy subjects and showed severe trabecular deficits in radial 
and tibial parameters, especially in Tb. vBMD (−21 to −38.5%), Tb. N. (−21.4 to −49.4%) and 
Tb. Sp. (+54.5 to +77.8%).(63-65) Although alterations were more severe in moderate-severe OI 
(type III/IV) than in mild OI (type I),(64) the trabecular deterioration in all types of OI exceeded 
that observed in fracture subjects in the current study. Recently, Rolvien and colleagues (2018) 
used HR-pQCT to compare bone microarchitecture in adults with OI and sex- and age-matched 
subjects with early-onset osteoporosis (EOOP; a condition distinct from postmenopausal 
osteoporosis in that it is characterized by low bone mass and the occurrence of fragility 
fractures before the age of 50 years) and healthy subjects. In accordance with other 
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publications, HR-pQCT revealed significant differences in radial and tibial Tb. vBMD as well 
as in a number of bone geometry and microstructural parameters in the OI cohort compared 
with healthy subjects. The EOOP cohort also showed a number of significant differences 
compared to healthy subjects, but the pattern was somewhat different to that for the OI 
cohort.(65)  
Together these studies suggest that pathological deficits in HR-pQCT bone parameters 
are at least the same if not larger than deficits associated with fracture in apparently healthy 
individuals, and that HR-pQCT assessment may be valuable in longitudinally monitoring 
disease progression and treatment efficacy.  
Study strengths and limitations  
The principal strength of this study was being able to relate expected fracture-associated 
differences to what can be reproducibly detected in a clinical setting using the XtremeCT I, 
while at the same time being PRISMA-compliant and statistically powered, and considering 
the influences of study quality, bias and heterogeneity. However, our study is not without 
limitations. Foremost, we must emphasize that our primary outcome, the percentage difference 
between HR-pQCT parameters obtained from fracture and control subjects, is not a measure of 
fracture risk, nor should it be interpreted as such (by contrast, the BoMIC study reports hazard 
ratios that convey the association between fracture-associated changes in HR-pQCT measures 
and incident fracture risk(59)). For instance, it would be inappropriate to conclude that tibial Tb. 
vBMD (difference = −9.1%) is a better fracture-risk predictor than tibial Ct. vBMD (difference 
= −2.8%) on the basis that it has a larger fracture-associated difference, since we have no 
information how a unit difference in either measure relates to overall difference in fracture risk. 
However, using the same example, we can conclude that individuals at risk of fracture will, on 
average, have a −9.1% and −2.8% deficit in tibial Tb. vBMD and Ct. vBMD, respectively. The 
studies included in this meta-analysis were predominantly retrospective, and although four 
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prospective studies were included, none focused on pediatric or young adult populations, 
representing a current gap in knowledge. Owing to the lack of individual-level data, the current 
meta-analysis was restricted to cohort-level data, which introduces a risk of aggregation bias(66) 
and limits investigation of individual-level covariates (e.g. bisphosphonate use) and 
redundancies in predictive performance arising from multicollinearities across 
parameters.(6,40,67) Use of aggregate data also prevented harmonization of FEA parameters, 
which are derived using a range of different boundary conditions and tissue properties across 
studies.(68) By comparison, the BoMIC study harmonized failure loads across cohorts by 
linearly calibrating values (across various boundary conditions and tissue moduli) to 
approximate axial conditions with a tissue modulus of 6.829 GPa.(59) 
Concluding remarks 
HR-pQCT has emerged as a powerful non-invasive bone imaging modality capable of 
assessing volumetric BMD, microarchitecture and strength, and distinguishing cancellous and 
cortical bone. To maximize the full potential of HR-pQCT in fracture-risk prediction, 
standardized imaging and analysis protocols and reporting guidelines for HR-pQCT are 
urgently needed, and improvement of reproducibility needs to be addressed. In conclusion, this 
meta-analysis confirms that HR-pQCT has promising clinical utility for fracture-risk prediction 
and will be pivotal in furthering our understanding of how disease and treatment contribute to 
changes in bone mass and architecture, and ultimately fracture risk.  
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Tables 
Table 1. HR-pQCT Parameters Included in Meta-analysis 
Parameter (Abbreviation) Description Units 
Volumetric bone mineral density measures (vBMD)  
1.! Total (Tt. vBMD) Total volumetric density mg HA/cm3 
2.! Cortical (Ct. vBMD) Cortical volumetric density mg HA/cm3 
3.! Trabecular (Tb. vBMD) Trabecular volumetric density mg HA/cm3 
Cortical (Ct.) measures  
4.! Area (Ct. Ar.) Mean area occupied by cortical bone mm2 
5.! Thickness (Ct. Th.) Mean cortical thickness, calculated 
indirectly as ratio of cortical bone 
volume to outer bone surface,(37) or 
directly(38)  
mm 
6.! Porosity (Ct. Po.) Cortical porosity, calculated using void-
voxel(38) or density-based method(34) 
% 
Trabecular (Tb.) measures  
7.! Thickness (Tb. Th.) Mean thickness of trabeculae mm 
8.! Number (Tb. N.) Mean number of trabeculae per unit 
length 
mm−1 
9.! Separation (Tb. Sp.) Mean distance between trabeculae mm 
Finite element analysis (FEA) measures  
10.!Stiffness Whole bone stiffness N/mm 
11.!Failure load Estimated maximum load N 
HA, hydroxyapatite 
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Figures 
 
 
Fig. 1. PRISMA diagram of flow of information through systematic review and meta-analysis. 
N = Number of studies; blue arrows = studies included; red arrows = studies omitted.  
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Fig. 2. Forest plot of fracture-associated differences in radial and tibial Tb. vBMD. Data are 
study-level per cent differences between individuals with and without fracture ± 95% CI, 
stratified by retrospective and prospective study design and sorted by participant age within 
each stratum. Red markers = tibial Tb. vBMD; black markers = radial Tb. vBMD; dashed line 
= no fracture reference. I2, τ and Q = heterogeneity statistics; N = number of data sets; p = p 
value for Q heterogeneity test; nf = number of fracture subjects; nc = number of control subjects; 
Tb. vBMD = trabecular volumetric BMD. Marker sizes are proportional to study-level weights. 
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Fig. 3. Forest plot of fracture-associated differences in radial and tibial failure load. Data are 
study-level per cent differences between individuals with and without fracture history ± 95% 
CI, stratified by retrospective and prospective study design and sorted by participant age within 
each stratum. Red markers = tibial failure load; black markers = radial failure load; dashed line 
= no fracture reference. I2, τ and Q = heterogeneity statistics; N = number of data sets, p = p-
value for Q heterogeneity test; nf = number of fracture subjects; nc = number of control subjects. 
Marker sizes are proportional to study-level weights.  
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Fig. 4. Influence of aggregate study quality score on fracture-associated differences in Tb. 
vBMD and failure load. Red band = 95% CI for overall estimate; red markers = score-specific 
estimate ± 95% CI; grey bars = number of data sets that received indicated aggregate quality 
score. RηιϕΡ  specifies percentage of heterogeneity explained by quality score. Tb. vBMD = 
trabecular volumetric BMD. Analyses of influence of quality on fracture-associated differences 
in other HR-pQCT parameters are provided in Fig. S10.  
 
Fig. 5. Risk of bias. (A, B) Funnel plots of study-level fracture-associated differences for Tb. 
vBMD (A) and failure load (B).  Black markers = study-level data; blue lines = fixed effect 
(FE) estimates; red lines = random effects (RE) estimates; black lines = theoretical 95% CI for 
FE estimate in absence of bias. Funnel plots for other HR-pQCT parameters are provided in 
Fig. S11. (C) Comparison of original (gray) and trim-and-filled (red) random effects estimates. 
Significance between original and filled estimates was assessed by Z-test and p values are 
reported. Ct. Ar. = cortical area; Ct. Po. = cortical porosity; Ct. Th. = cortical thickness; Ct. 
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vBMD = cortical volumetric BMD; Tb. N. = trabecular number; Tb. Sp. = trabecular 
separation; Tb. Th. = trabecular thickness; Tb. vBMD = trabecular volumetric BMD; Tt. 
vBMD = tibial volumetric BMD. 
 
 
Fig. 6. Heterogeneity and sensitivity analyses for Tb. vBMD and failure load. (A, B) Single-
study exclusion sensitivity analysis of Tb. vBMD (A) and failure load (B). Individual data sets 
were omitted from meta-analysis and influence on fracture-associated difference ± 95% CI (red 
left axis, shaded bands) and heterogeneity (black right axis, solid curve) was assessed. (C, D) 
Cumulative-study exclusion sensitivity analysis of Tb. vBMD (C) and failure load (D). Data 
sets were cumulatively removed according to maximal Q-reduction criteria and homogeneity 
threshold (Th, dashed black line) was estimated as percentage of studies that must be removed 
to obtain homogeneous data set (p>0.05 by Q-test). Red left axis, shaded bands = fracture-
associated difference ± 95% CI; black right axis, solid curve = p values for Q heterogeneity 
test; gray bands = overall 95% CI; Tb. vBMD = trabecular volumetric BMD. Sensitivity 
analyses for other HR-pQCT parameters are provided in Fig. S12.  
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Fig. 7. Fracture-associated differences in radial and tibial HR-pQCT parameters acquired from 
prospective and retrospective studies. Fracture-associated differences (dif) ± 95% CI in HR-
pQCT radial (black) and tibial (red) measures acquired from retrospective (ret; round markers) 
and prospective (pro; square markers) studies. Shaded red/black bands = overall estimate ± 
95% CI for specified parameter and scanned region; dashed line = no fracture reference; Ct. 
Ar. = cortical area; Ct. Po. = cortical porosity; Ct. Th. = cortical thickness; Ct. vBMD = cortical 
volumetric BMD; I2 = heterogeneity statistic; N = number of data sets (marker sizes are 
proportional to N); nc = number of non-fracture subjects; nr = number of fracture subjects; Tb. 
N. = trabecular number; Tb. Sp. = trabecular separation; Tb. Th. = trabecular thickness; Tb. 
vBMD = trabecular volumetric BMD; Tt. vBMD = tibial volumetric BMD. 
Detailed statistics are provided in Table S5.  
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Fig. 8. In vivo short-term reproducibility of HR-pQCT measures and implications for fracture 
prediction. (A–D) Meta-analytic estimates of in vivo HR-pQCT reproducibility of density- (A), 
cortical- (B), trabecular- (C) and FE model- (D) parameters obtained from radial (rad.; black 
markers) and tibial (tib.; gray markers) scans. Study-level root-mean-squared per cent 
coefficients of variance (CV%RMS) were pooled as weighted means. Weights were degrees of 
freedom = m(n−1), where m = number of subjects, n = repeat measures. Red lines/bands = 
means ± 95% CI, radial and tibial reproducibility was compared by Z-test, p values are shown. 
(E, F) Forest plots of fracture-associated differences (dif.) ± 95% CI in radial (E) and tibial (F) 
HR-pQCT measures overlaid with least-significant change (red bands), LSC = 2.77(CV%RMS). 
Black markers = reliable measures (no overlap with LSC); gray markers = borderline reliable 
measures (partial overlap with LSC); red markers = unreliable measures (complete overlap 
with LSC); black dashed line = no fracture reference, markers are proportional to number of 
data sets N; Ct. Ar. = cortical area; Ct. Po. = cortical porosity; Ct. Th. = cortical thickness; Ct. 
vBMD = cortical volumetric BMD; LSC = least significant change; Tb. N. = trabecular 
number; Tb. Sp. = trabecular separation; Tb. Th. = trabecular thickness; Tb. vBMD = trabecular 
volumetric BMD; Tt. vBMD = tibial volumetric BMD. 
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Appendix 
Analysis of heterogeneity and bias 
To quantify the extent of inconsistency (i.e. heterogeneity) between data sets, we calculated � 
and �Ρ heterogeneity statistics. � is a measure of total variation and was calculated as the sum 
of the weighted squared differences between study-level differences ���λ and the fixed effect 
estimate ���νοπ: 
� =θρ��(���λ)σΡ ∙ Τ���λ − ���νοπΥΡτ	
υ
λϖω
 
 
(A1) 
where � is the study index,  ���νοπ = ∑ ψζ({λ∀|)}∼{λ∀||∑ ψζ({λ∀|)}∼|   and � is the number of studies. 
Q is a �Ρ-distributed statistic with � − 1 degrees of freedom (��). The p value corresponding 
to the Q statistic was used to test the null hypothesis that all data sets reported the same effect. 
Q statistics derived for subgroups were denoted Qwithin. �Ρ is a related heterogeneity statistic 
that describes the percentage of variance that is due to heterogeneity: 
�Ρ =  ��� − 1	  ���
σω
 
 
(A2) 
Heterogeneity was further assessed by single-study and cumulative-study exclusion plots(14). 
The homogeneity threshold TH was calculated from cumulative exclusion analysis and 
specifies the percentage of studies that need to be removed (according to maximal Q-reduction 
criteria) before a homogeneous set of studies is attained, as determined by the p value PQ 
corresponding to the Q heterogeneity statistic.(14) Biases were visually assessed using funnel 
plots, and the theoretical impact of bias was determined by trim-and-fill analysis.(69) 
Meta-analysis 
Study-level outcomes were synthesized under the assumptions of a random effects model to 
obtain an overall outcome ���ν : 
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���ν = ∑ (���λ ∙ �λ)λ∑ (�λ)λ   
(A3) 
Where the random effects study-level weights �λ were estimated as:  
�λ = 1��(���λ)Ρ + �Ρ  
(A4) 
And the interstudy variance �Ρ was approximated using the DerSimonian–Laird estimator: 
�Ρ = � − (� − 1)�  
where � = ∑ ��(���λ)σΡλ − ∑ Τψζ({λ∀|)}∼Υ∼|∑ ψζ({λ∀|)}∼|  
 
(A5) 
Q is the heterogeneity statistic (Eqn. A1), c is a scaling factor, and N is the number of data sets. 
The standard error ��(���ν ) corresponding to the overall outcome was estimated as: 
��(���ν ) 	= 1∑ �λλ  
 
(A6) 
and confidence intervals were constructed using critical values �ωσ Ρ  obtained from a z-
distribution: 
±�� = ±�ωσ/Ρ	 ∙ ��(���ν )  
(A7) 
where � = 0.05 corresponds to a 95% significance level. Outcomes were compared using the  
Z-test.(69) 
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